MedPath

江西制药有限责任公司

Ownership
-
Established
1996-06-10
Employees
-
Market Cap
-
Website
http://www.jxzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

344

NMPA:344

Drug Approvals

Irsogladine Maleate

Product Name
马来酸伊索拉定
Approval Number
国药准字H20020373
Approval Date
Jul 4, 2024
NMPA

Micronomicin Sulfate

Product Name
硫酸小诺霉素
Approval Number
国药准字H10910020
Approval Date
Jul 4, 2024
NMPA

Gentamycin Sulfate

Product Name
硫酸庆大霉素
Approval Number
国药准字H36020688
Approval Date
Jul 4, 2024
NMPA

Kanamycin Monosulfate

Product Name
单硫酸卡那霉素
Approval Number
国药准字H36020740
Approval Date
Jul 4, 2024
NMPA

Atorvastain Calcium Tablets

Product Name
阿托伐他汀钙片
Approval Number
国药准字H20234167
Approval Date
Jun 4, 2024
NMPA

Pazufloxacin Mesylate Injection

Product Name
宣搏
Approval Number
国药准字H20070235
Approval Date
Apr 18, 2024
NMPA

Pazufloxacin Mesylate Injection

Product Name
宣搏
Approval Number
国药准字H20061014
Approval Date
Apr 18, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H36020830
Approval Date
Apr 28, 2023
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H36022241
Approval Date
Apr 28, 2023
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H36020826
Approval Date
Apr 28, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 35
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.